Operating
Humana·Cash Flow Statement·16 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Change in benefits payable | — | — | — | $1B | -$391M | -$971M | -$121M | $2.7B |
| Change in receivables | $165M | — | $560M | $1.8B | $45M | -$1.8B | $586M | $1.9B |
| Change in other assets | -$495M | — | -$745M | $686M | $0 | $716M | $799M | $1.4B |
| Increase (Decrease) in Other Operating Assets | -$495M | — | -$745M | $686M | $0 | $716M | $799M | $1.4B |
| Net cash from operating activities | $1.2B | $1.9B | — | $331M | $1.3B | $971M | — | $1.3B |
| Net income | $678M | $480M | — | $1.2B | $543M | $194M | — | $1.2B |
| Change in other liabilities | — | -$171M | — | $193M | $817M | $307M | $5M | $452M |
| Depreciation and amortization | $228M | $228M | $226M | $200M | $196M | $191M | $186M | $183M |
| Depreciation | $228M | $228M | $226M | $200M | $196M | $191M | $186M | $183M |
| Change in deferred revenue | $12M | -$118M | — | $5M | $9M | $0 | $91M | -$87M |
| Stock-based compensation | $55M | $53M | $54M | $49M | $61M | $83M | $48M | $51M |
| Other working capital changes | $11M | $32M | $32M | $7M | -$7M | $27M | -$27M | $21M |
| Equity in earnings (losses) of equity method investees | -$17M | -$16M | -$37M | -$43M | -$19M | -$26M | -$14M | -$16M |
| Amortization | $15M | $15M | $14M | $15M | $15M | $13M | $8M | $11M |
| Impairment of long-lived assets | $54M | $42M | $108M | $9M | $5M | $0 | $14M | $2M |
| Net gains (losses) on investments | -$1M | $10M | $14M | $2M | $11M | $53M | -$116M | -$1M |